Obligations of the End User Sample Clauses

Obligations of the End User. The End User undertakes: (a) to use the Software strictly in accordance with this ▇▇▇▇ for its own internal business purposes only and not to disclose the Software or Documentation to any third party and not to use the Software or Documentation to provide a data processing or application service to any third party; not to copy the Software in any way or format except as an uninstalled back up copy; not to disassemble, decompile, reverse engineer, translate, vary, modify or otherwise interfere with the Software; (b) to copy and use the Documentation solely in connection with the proper use of the Software; (c) to communicate with the Licensor in English; (d) to effect and maintain adequate security measures to safeguard the Software from access or use by any unauthorized person; (e) to maintain accurate and up-to-date records of the number, version and location of all copies of the Software and the number of named and / or concurrent, customer and registration form users, or the number of the configured workflows and to permit the Licensor reasonable control of the same; (f) to supervise and control the use of the Software in accordance with this ▇▇▇▇ and in accordance with the Documentation; (g) to replace the current version of the Software with the upgraded version forthwith upon receipt; (h) to notify the Licensor of any change it has made to the platform of the system or systems on which the Software is running; (i) not to cause Licensor by its acts or omissions to suffer any claim, cost, loss or damage to Licensor’s good name, or the good name of the Software or to Licensor’s intellectual property rights; (j) not to provide, sub-license or otherwise make available the Software in whole or in part (including but not limited to program listings, object and source program listings, object code and source code), in any form to any purpose except for the strictly limited purpose set out in this ▇▇▇▇.
View SourceView Similar (27)
Obligations of the End User. 6.1. The End User undertakes to Use the UKMVS solely for the Purpose and in accordance with this ▇▇▇▇ and the EU Falsified Medicines Directive and the Delegated Regulation. 6.2. The End User represents, warrants and undertakes that: 6.2.1. the End User is responsible for and shall maintain the security of its system(s) and the confidentiality of its credentials and passwords to connect to the UKMVS, and is solely responsible for any activities carried out through its account within the UKMVS and on its system(s), including for the correctness and accuracy of any information or Data uploaded or generated by the End User on the UKMVS; 6.2.2. the End User’s own system(s) and any connection or access by the End User to the UKMVS shall be protected by appropriate security measures, as necessary to protect against unauthorised access, interception, disruption or other Security Breach, including the security measures as notified by SecurMed UK to the End User from time to time; and 6.2.3. the End User shall notify SecurMed UK of any Security Breach as soon as it becomes aware of such Security Breach and shall take all necessary measures to mitigate such Security Breach, in so far as this is possible, and comply with any of SecurMed UK’s reasonable requirements in connection with the same. 6.3. Notwithstanding any other provision of this ▇▇▇▇, the End User represents, warrants and undertakes that it shall not: 6.3.1. Use the UKMVS in any unlawful manner, for any unlawful purpose, or in any manner inconsistent with this ▇▇▇▇ or the EU Falsified Directive Medicines and Delegated Regulation or act fraudulently or maliciously (for example (without limit), by hacking into or inserting malicious code, including viruses, or inaccurate, false or harmful data into the UKMVS); 6.3.2. infringe any Intellectual Property Rights in or relating to the UKMVS, or those of SecurMed UK or any third party in relation to the use of the UKMVS; or 6.3.3. Use the UKMVS in a way that could, or is reasonably likely to, damage, disable, overburden, impair or compromise the UKMVS or interfere with other Users. 6.4. (Bulk) verifications can only be performed by End Users in respect of products under their physical control. Decommissioning of unique identifiers by End Users can only be performed by or after verifying and scanning individual packs under their physical control and in hand. 6.5. The End User may authorise its End User Representatives to Use the UKMVS on behalf of the End User as ...
View SourceView Similar (3)
Obligations of the End User. 4.1. As the End User you are obliged to: a) use the Applications only in accordance with the purpose designated by the Provider; b) use the Applications only in a manner, that complies with all applicable laws in the jurisdiction, in which the End User uses the software, including, but not limited to, applicable restrictions concerning copyright and other intellectual property rights; c) use the Applications only in a manner that shall not violate our rights or any third- party rights; d) undertake any and all security measures to ensure proper functioning of the Applications (including adequate technical, administrative and physical safeguards); e) refrain from using or otherwise exporting or re-exporting the Applications except as authorized by the law of the jurisdiction in which the Applications were acquired. In particular, but without limitation, any export or re-export of the Applications must not violate any sanctions or embargoes imposed on countries by (i) the Czech Republic, (ii) the European Union, (iii) the United States of America, or (iv) the United Nations; f) refrain from usage of the Applications in any countries and territories which are subject to sanctions or embargoes imposed by (i) the Czech Republic, (ii) the European Union, (iii) the United States of America, or (iv) the United Nations; g) refrain from usage of the Applications in a manner that would lead directly or indirectly to, without limitation, the development, design, manufacture, or production of nuclear missile or chemical or biological weapons; h) refrain from any conduct such as decompiling, disassembly or reverse engineering of the Applications; i) refrain from any conduct, that would cause building a similar or competitive product of the Applications; j) refrain from any conduct, that would cause removing, modification, obscuring, translation or reproduction of the Applications as well as infringement of copyright or proprietary notices contained in the Applications; and k) indemnify the Provider without undue delay for all harm (including lost profit) suffered by the Provider as a result of the breach of the End User’s obligations pursuant this ▇▇▇▇.
View SourceView Similar (3)
Obligations of the End User. The End User undertakes to connect, to access to and to use the MVO Portugal National System (serving the territory in which the End User is authorized or entitled) to verify the authenticity of the unique identifier of medicinal products and decommission the unique identifier in accordance with these Terms and all its obligations under the EU Directive on Falsified Medicines and the Delegated Regulation. The End User warrants that: the End User is responsible for maintaining the security of its system and the confidentiality of its credentials and passwords to connect to the MVO Portugal National System, and is solely responsible for any activities carried out through its connection/account and on its system, including for the correctness and accuracy of any information or Data uploaded or generated by the End User on the MVO Portugal National System; the End User’s own system and any connection or access by the End User to the MVO Portugal National System shall be protected by appropriate security measures, as necessary to protect against unauthorized access, interception, disruption or other Security Breach, including the security measures as notified by MVO Portugal to the End User from time to time; and the End User shall notify MVO Portugal of any Security Breach as soon as it becomes aware of such Security Breach and shall take all necessary measures to mitigate such Security Breach, in so far as this is possible. In any case, the End User must not (i) use the MVO Portugal National System in any unlawful manner, for any unlawful purpose, or in any manner inconsistent with these Terms or the EU Falsified Directive Medicines and Delegated Regulation, or act fraudulently or maliciously, for example, by hacking into or inserting malicious code, including viruses, or inaccurate, false or harmful data into the MVO Portugal National System; (ii) infringe any Intellectual Property Rights relating to the MVO Portugal National System, or those of any third party in relation to the use of the MVO Portugal National System, or (iii) use the MVO Portugal National System in a way that could damage, disable, overburden, impair or compromise the MVO Portugal National System or interfere with other Users.
View SourceView Similar (2)
Obligations of the End User. 4.1 The End - user undertakes to: 4.1.1 Use the equipment for the purpose that it is intended and in accordance with any reasonable manufacturers’ instructions and user manual as to the use thereof; 4.1.2 Keep the equipment in its possession and custody and control at its premises in accordance with the same policies and procedures that the End user applies in respect of its own assets and equipment; 4.1.3 Advise the supplier prior to relocation equipment. 4.1.4 Allow the supplier or its representatives reasonable access to the inspection of the equipment on prior written notice; 4.1.5 Undertakes to ensure that the installation area, access ways, electrical supply and where relevant, the IT configuration of its premises and other equipment or any network are suitable for the installation, passage and electrical/or electronic connection of the equipment when it is delivered for installation and thereafter.
View Source
Obligations of the End User. The End-user is required to provide all necessary, complete and correct contact details (such as name, address, email address, company registration number if any) and payment information (such as VAT number, bank account number/IBAN, bank name, BIC code), as well as – if necessary – complete and correct data of any person representing them or whom they wish to give access to part of the Services (e.g., employees, fleet managers), during the registration process on the Platform and/or on the Application. The End-User is also obliged to ensure that it is legally entitled and authorized to introduce personal data or other information of third parties, like fleet managers or employees, as well as to inform such persons in advance thereof. Should a Business End-User give access to part of the Services to natural persons working for said End-User, it shall remain responsible for them and ensure they comply at all times with this Agreement (e.g., fleet managers, employees). In the event of a change in the data provided, the End-User shall immediately notify EDI and provide EDI with the updated data. End-User should report any changes, in particular changes to the bank account number, invoicing address and/or e-mail address, not later than within one (1) calendar month before the change becomes effective. Unless the law provides for otherwise, the End-User shall be responsible for any possible errors in documents, payments, Services or other damage, that are caused by End-User’s failure to comply with its duty to provide correct and complete information or timely update it and EDI reserves the right to not provide a Service in case of incorrect, incomplete or too late transmission of information by an End- User and shall notify the End-User accordingly. The End-User is obliged to inform any person related to them (e.g., employees) using any Services of the content of this Agreement and shall be responsible to ensure their respect thereof. The End-User shall not: a) use the Services in a way that disrupts the functioning of the Website, the Platform, the Application or any of their elements, as well as Services performed for other End-Users; b) introduce any illegal content to the Platform, the Website or the Application, which violates the law or decency, including, in particular, introducing any malicious software or tracking software; c) indicate personal data of third parties (e.g., fleet managers or account administrators), the disclosure of which is not autho...
View Source
Obligations of the End User. ‌ The End User undertakes: 6.1. to use the Software strictly in accordance with this EULA for its own business purposes only and not to disclose the Software or Documentation to any third party; not to disassemble, decompile, reverse engineer, translate, vary, modify or otherwise interfere with the Software; 6.2. to copy and use the Documentation solely in connection with the proper use of the Software; 6.3. to communicate with the Licensor in English or in Hungarian; 6.4. to effect and maintain adequate security measures to safeguard the Software from access or use by any unauthorized person; 6.5. to maintain accurate and up-to-date records of the number, version and location of all copies of the Software; 6.6. to supervise and control the use of the Software in accordance with this EULA and in accordance with the Documentation; 6.7. to replace the current version of the Software with the updated version forthwith upon receipt; 6.8. not to cause Licensor by its acts or omissions to suffer any claim, cost, loss or damage to Licensor’s good name, or the good name of the Software or to Licensor’s intellectual property rights; 6.9. not to provide, sub-license or otherwise make available the Software in whole or in part, in any form to any purpose except for the strictly limited purpose set out in this EULA.
View Source
Obligations of the End User. 5.1. The End-User undertakes to connect to, access and use the IMVS to verify the authenticity of the unique identifier of medicinal products and decommission the unique identifier in accordance with this End-User Licence Agreement and all its obligations under the EU Directive on Falsified Medicines and the Delegated Regulation. 5.2. The End-User warrants that: 5.2.1. the End-User is responsible for maintaining the security of its system(s) connected to the IMVS and the confidentiality of its credentials and passwords used to connect to the IMVS (which shall include the appointment of a suitably qualified Super User), and is solely responsible, subject to Section 14.6 of this End-User Licence Agreement, for any activities carried out through its account /connection and on its system(s), including for the correctness and accuracy of any information or Data uploaded or generated by the End-User on the IMVS; 5.2.2. the End-User’s own system(s) and any connection or access by the End-User to the IMVS shall be protected by appropriate security measures, as necessary to protect against unauthorised access, interception, disruption or other Security Breach, including the security measures as notified by IMVO to the End-User from time to time; and 5.2.3. the End-User shall notify IMVO of any Security Breach as soon as it becomes aware of such Security Breach and shall take all necessary measures to mitigate such Security Breach, in so far as this is possible; and 5.2.4. where the End-User utilises a system provided by the End-User IT Software Provider to access the IMVS and the End-User IT Software Provider is an external provider, that: 5.2.4.1. the End-User has a contract with the End-User IT Software Provider; and 5.2.4.2. that contract has provisions that require reasonable technical measures to be in place to protect against unauthorised access, interception, disruption to the IMVS or other Security Breach via the End-User system; and 5.2.5. the End-User that is a Healthcare Institution shall not cause IMVO to breach the terms of the Co-Operation Agreement or the provisions of the EU Directive on Falsified Medicines and the Delegated Regulation by its use of Data Files to decommission unique identifiers. 5.3. In any case, the End-User shall not (i) use the IMVS in any unlawful manner, for any unlawful purpose, or in any manner inconsistent with this End-User Licence Agreement or the EU Directive on Falsified Medicines and the Delegated Regulation, or act fra...
View Source
Obligations of the End User. The End User acknowledges and agrees the End User is responsible for ensuring that: 1. The product has been installed, configured, and tested as provided in the Documentation. 2. The computer and device network (“Network”) provided by the End User at the End User’s site has been designed, installed, and configured in full compliance with accepted standards regarding such Networks, including power (and backup power). 3. The provided physical address for the End User’s site is accurate for purposes of E911 registration. 4. Each IP phone will always be powered on, will always have a reliable electrical supply and will always be connected to the Internet via the Network supplied and supported by the Recipient. 5. No modifications are made to the product. 6. E911 Caution labels are placed on or near each IP Phone.
View Source

Related to Obligations of the End User

  • OBLIGATIONS OF THE OWNER 5.1 The Owner agrees to provide the requisite access and authority for Coinllectibles to have access to information necessary for Coinllectibles to carry out the Services hereunder. 5.2 The Owner shall pay Coinllectibles the Fees (each of the Fees to be paid in full in one tranche and without set-off) as follows: Minting Fee in accordance with Clause 6.1(a) below; and Commission in accordance with Clause 6.1(b) below. 5.3 The Owner shall execute the Power of Attorney in accordance with Clause 9 below.

  • CONDITIONS OF THE OBLIGATIONS OF THE COMPANY The obligations of the Company to sell and deliver the portion of the Shares required to be delivered as and when specified in this Agreement are subject to the conditions that at the Closing Date or the Option Closing Date, as the case may be, no stop order suspending the effectiveness of the Registration Statement shall have been issued and in effect or proceedings therefor initiated or threatened.

  • OBLIGATIONS OF THE BUYER a. The Buyer has furnished to the Company in Exhibit B hereto such information regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it as required to effect the registration of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably request. The Company shall notify the Buyer in writing of any other information the Company reasonably requires from the Buyer in connection with any Registration Statement hereunder. The Buyer will as promptly as practicable notify the Company of any material change in the information set forth in Exhibit B, other than changes in its ownership of the Common Stock. b. The Buyer agrees to cooperate with the Company as reasonably requested by the Company in connection with the preparation and filing of any amendments and supplements to any Registration Statement hereunder. c. The Buyer agrees that, upon receipt of any notice from the Company of the happening of any event or existence of facts of the kind described in Section 3(f) or any notice of the kind described in the first sentence of Section 3(e), the Buyer will immediately discontinue disposition of Registrable Securities pursuant to any registration statement(s) covering such Registrable Securities until the Buyer’s receipt (which may be accomplished through electronic delivery) of the copies of the filed supplemented or amended registration statement and/or prospectus contemplated by Section 3(f) or the first sentence of Section 3(e). In addition, upon receipt of any notice from the Company of the kind described in the first sentence of Section 3(e), the Buyer will immediately discontinue purchases or sales of any securities of the Company unless such purchases or sales are in compliance with applicable U.S. securities laws. Notwithstanding anything to the contrary, the Company shall cause its Transfer Agent to deliver as promptly as practicable shares of Common Stock without any restrictive legend in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to which the Buyer has received a Purchase Notice or VWAP Purchase Notice (both as defined in the Purchase Agreement) prior to the Buyer’s receipt of a notice from the Company of the happening of any event of the kind described in Section 3(f) or the first sentence of Section 3(e) and for which the Buyer has not yet settled.

  • OBLIGATIONS OF THE SUPPLIER In addition to the Article 4.2 of the GPC, it is specified that:

  • Conditions of the Obligations of the Purchasers The obligations of the several Purchasers to purchase and pay for the Purchased Notes will be subject to the accuracy of the representations and warranties on the part of the Company herein, to the accuracy of the statements of Company officers made pursuant to the provisions hereof, to the performance by the Company of its obligations hereunder and to the following additional conditions precedent: (a) On the date of execution of the Purchase Agreement and on the Closing Date, you shall have received from Deloitte & Touche LLP, independent registered public accounting firm with respect to the Company within the meaning of the Securities Act and the Securities Act Rules and Regulations, a letter, dated such a date, in form and substance reasonably satisfactory to you containing statements and information of the type customarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information contained or incorporated by reference in the Registration Statement, the Time of Sale Prospectus and the Prospectus; provided that the letter delivered on the Closing Date shall use a “cut-off” date no more than three business days prior to the Closing Date. (b) The Registration Statement shall remain effective and at the Closing Date, no stop order suspending the effectiveness of the Registration Statement shall have been issued, no proceedings for such purpose shall have been instituted or, to the knowledge of the Company or you, shall be contemplated by the Commission and the Company has not received a notice of objection to the use of the Registration Statement as an automatic shelf registration statement. The Prospectus and each issuer “free writing prospectus” shall have been timely filed with the Commission under the Securities Act, as required; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Purchasers. (c) Subsequent to the date of this Agreement, there shall not have occurred (A) any change or any development involving a prospective change not contemplated by the Time of Sale Prospectus as of the date of this Agreement in or affecting particularly the business or properties of the Company which, in the judgment of a majority in interest of the Purchasers including you, materially impairs the investment quality of the Purchased Notes, and (B) (i) any downgrading in the rating of the Purchased Notes or any other debt securities or preferred stock of or guaranteed by the Company or any of its subsidiaries by any “nationally recognized statistical rating organization” (registered under Section 15E of the Exchange Act) or (ii) any public announcement that any such organization has under surveillance or review its rating of the Purchased Notes or any other debt securities or preferred stock of or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications of a possible upgrading, and no implication of a possible downgrading, of such rating) or any announcement that the Company has been placed on negative outlook. (d) You shall have received an opinion, dated the Closing Date, of a counsel for the Company, in substantially the form attached hereto as Exhibit A. In addition, such counsel shall state that such counsel has participated in conferences with officers, counsel and other representatives of the Company, representatives of the independent registered public accounting firm for the Company and representatives of the Purchasers at which the contents of the Registration Statement, the Time of Sale Prospectus and the Prospectus and related matters were discussed; and, although such counsel is not passing upon and does not assume responsibility for the accuracy, completeness or fairness of the statements contained in the Registration Statement, the Time of Sale Prospectus and the Prospectus (except as to the matters referred to in their opinion), on the basis of the foregoing (relying as to matters of fact to a large extent upon the opinions of officers, counsel and other representatives of the Company), no facts have come to the attention of such counsel which lead such counsel to believe that (a) the Registration Statement, when it became effective and as of the date of this Agreement, contained any untrue statement of a material fact or omitted to state any material fact required to be stated therein or necessary to make the statements therein not misleading, (b) the Time of Sale Information as of the Time of Sale and as of the date hereof, contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or (c) the Prospectus as of its date and as of the date hereof, contained any untrue statement of a material fact or omitted to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading (it being understood that such counsel need make no comment with respect to the financial statements and other financial data included in the Registration Statement, the Time of Sale Prospectus or Prospectus or incorporated therein or as to the Statement of Eligibility and Qualification on Form T l of the Trustee under the Indenture). (e) The Purchasers shall have received from counsel for the Purchasers, an opinion dated the Closing Date, with respect to the matters as the Purchasers shall reasonably request and the Company shall have furnished to such counsel such documents as they reasonably request for the purpose of enabling them to pass on such matters. (f) You shall have received a certificate of the Chief Executive Officer, President or any Vice President of the Company and a principal financial or accounting officer of the Company, dated the Closing Date, in which such officers shall state, to the best of their knowledge after reasonable investigation, (i) the representations and warranties of the Company in this Agreement are true and correct in all material respects, (ii) the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied at or prior to the Closing Date, (iii) no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for such purpose have been instituted, are pending or, to the best knowledge of the Company, threatened by the Commission, and (iv) that, subsequent to the date of the most recent financial statements set forth or incorporated by reference in the Time of Sale Prospectus or the Prospectus, there has been no material adverse change, nor any development or event reasonably likely to involve a prospective material adverse change, in the financial condition, business, properties or results of operations of the Company and its subsidiaries taken as a whole, except as set forth or contemplated in the Time of Sale Prospectus or the Prospectus. (g) The Company will furnish you with such conformed copies of such opinions, certificates, letters and documents as you reasonably request. In case any such condition shall not have been satisfied, this Agreement may be terminated by you upon notice in writing or by telecopy to the Company without liability or obligation on the part of the Company or any Purchaser, except as set forth in Section 12 hereof.